CD274 and neoplasm: They found that PEI hydrogel (PEIGel) encapsulating immune checkpoint blockade (ICB) inhibitors demonstrated synergistic effects with anti-PD-L1 antibodies, eliminating primary tumors and distant metastases, thereby preventing tumor recurrence after surgical resection (97).